Stroke Research & Therapy

Therapeutic Profile of Stroke Patients Managed with Neuroprotective Regimens

Development of safe and affective neuroprotective drugs for stroke management has been a medical subject for a number of years. Several clinical trials were withdrawn in vainness due to lack of optimum therapeutic outcomes. Nonetheless, recently a number of encouraging facts have highly supported demanding enthusiasm linked to management of stroke. Neuroprotectives have worked in growing window time period of suitability fostering endovascular thrombectomy. Stroke is a notable cause of morbidity and mortality around the globe. Greater understanding of the pathophysiology of neuronal damage in ischemic stroke has created interest in neuroprotection as a managing strategy. Neuroprotection is an increasingly recognized management strategy in ischemic stroke that promises to involvement clinicians in reducing stroke mortality rates and improving the quality of life of survivors.

Author(s):

Ishaq Khan^1*, Javeria Khan², Gazala Shams³ and Javed Shabbir⁴

Abstract | Full-Text | PDF

Share this